The biotech said the inducement awards carry a 10-year term, a $106.02 exercise price and vest over four years for newly hired non-executive staff.
Dianthus Therapeutics said it granted inducement stock options to six newly hired, non-executive employees, totaling 87,000 shares. The awards carry a 10-year term, an exercise price of $106.02 per share and vest over four years, consistent with the company’s use of equity incentives to help recruit staff without relying on a traditional shareholder-approved plan.